You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 35 No. 7, July 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Modification of Tardive Dyskinesia and Spasmodic Torticollis by Apomorphine

Possible Role of Dopamine Autoreceptors

Eduardo S. Tolosa, MD

Arch Neurol. 1978;35(7):459-462.


Abstract

• A group of 16 patients afflicted with involuntary movement disorders received subcutaneous injections of the direct dopamine agonist, apomorphine hydrochloride. Paradoxically, these injections were generally followed by a reduction of dyskinesia; this was most noticeable in patients with tardive dyskinesia and was only mild in some patients with spasmodic torticollis. Preferential stimulation by apomorphine of inhibitory dopamine presynaptic receptors (so-called dopamine autoreceptors) is proposed as the most likely explanation for the observed antidyskinetic effect of this drug. The results of this study also suggest that direct dopamine agonists may be used clinically to attenuate CNS dopaminergic transmission, especially when use of antidopminergic drugs such as the neuroleptics is contraindicated, as in the case of tardive dyskinesia.



Author Affiliations

From the Department of Neurology, University of Minnesota School of Medicine, Minneapolis.


Footnotes

Accepted for publication Sept 26, 1977.

Reprint requests to Department of Neurology, Box 468-Mayo, University of Minnesota School of Medicine, Minneapolis, MN 55455 (Dr Tolosa).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Apomorphine and Schizophrenia: Treatment, CSF, and Neuroendocrine Responses
Levy et al.
Arch Gen Psychiatry 1984;41:520-524.
ABSTRACT  

Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience
Jeste and Jed Wyatt
Arch Gen Psychiatry 1982;39:803-816.
ABSTRACT  

Neurochemical and behavioral evidence for a selective presynaptic dopamine receptor agonist
Goodale et al.
Science 1980;210:1141-1143.
ABSTRACT  

Bromocriptine and Buccolinguofacial Dyskinesias in Patients With Senile Dementia: A Quantitative Study
Delwaide and Hurlet
Arch Neurol 1980;37:441-443.
ABSTRACT  

Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists
Skirboll et al.
Science 1979;206:80-82.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.